Hologic Inc. (HOLX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
38.46-0.27 (-0.70%)
At close: 4:00 PM EDT
People also watch:
ISRGHSICXRAYVARIDXX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open38.65
Prev Close38.73
Bid37.25 x 100
Ask0.00 x
Day's Range38.38 - 38.75
52wk Range31.84 - 42.58
1y Target EstN/A
Market Cap10.67B
P/E Ratio (ttm)42.40
Beta0.61
Volume1,873,421
Avg Vol (3m)2,731,026
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters4 days ago

    UPDATE 4-FDA recommends Zika testing for all blood donated in U.S.

    CHICAGO/TAMPA, Fla., Aug 26 (Reuters) - The U.S. Food and Drug Administration recommended on Friday that all blood donated in the United States and its territories be tested for Zika virus, as it moves to prevent transmission of the virus through the blood supply. The agency said its decision to expand blood screening in the United States was based on concerns about more cases of local transmission in Florida, the growing number of travel-related infections and concerns that Zika-tainted blood could unwittingly be given to a pregnant woman, putting her unborn baby at risk of severe birth defects.

  • New Zika Screening Rule Could Boost Hologic Sales Growth
    Investor's Business Daily4 days ago

    New Zika Screening Rule Could Boost Hologic Sales Growth

    The advisory that all U.S. blood centers screen for Zika is good news for Hologic's Procleix test.

  • Reuters5 days ago

    FDA advises Zika testing for all donated blood in the U.S.

    The U.S. Food and Drug Administration issued a revised guidance on Friday recommending universal testing of donated blood for Zika virus in the U.S. and its territories. The FDA recommended that all states and U.S. territories screen individual units blood with a screening test authorized for use by the FDA. The agency had recommended in February that blood should no longer be collected from regions where the Zika virus is circulating, and that blood needed for transfusions be obtained from areas of the country without active transmission.